Similar articles

• Drug-induced lupus following treatment with infliximab in rheumatoid arthritis.

  Favalli EG, Sinigaglia L, Varenna M, Arnoldi C. Favalli EG, et al. Lupus. 2002;11(11):753-5. doi: 10.1191/0961203302lu236cr. Lupus. 2002. PMID: 12475006
• Onset of systemic lupus erythematosus after conversion of infliximab to adalimumab treatment in rheumatoid arthritis with a pre-existing anti-dsDNA antibody level.

  van Rijthoven AW, Bijlsma JW, Canninga-van Dijk M, Derksen RH, van Roon JA. van Rijthoven AW, et al. Rheumatology (Oxford). 2006 Oct;45(10):1317-9. doi: 10.1093/rheumatology/kel227. Epub 2006 Jul 13. Rheumatology (Oxford). 2006. PMID: 16844698 No abstract available.
• Infliximab-induced lupus or rheumatoid arthritis (RA) overlapping with systemic lupus erythematosus (SLE) unmasked by infliximab.

  Novak S, Cikes N. Novak S, et al. Clin Exp Rheumatol. 2004 Mar-Apr;22(2):268. Clin Exp Rheumatol. 2004. PMID: 15083903 No abstract available.
• Infliximab-related lupus and associated valvulitis: a case report and review of the literature.

  Chadha T, Hernandez JE. Chadha T, et al. Arthritis Rheum. 2006 Feb 15;55(1):163-6. doi: 10.1002/art.21702. Arthritis Rheum. 2006. PMID: 16463396 Review. No abstract available.
• TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.

  Williams VL, Cohen PR. Williams VL, et al. Int J Dermatol. 2011 May;50(5):619-25. doi: 10.1111/j.1365-4632.2011.04871.x. Int J Dermatol. 2011. PMID: 21506984 Review.